Annals of Diagnostic Pathology
Volume 10, Issue 4 , Pages 197-204, August 2006

Aggressive angiomyxoma of male genital region. Report of 4 cases with immunohistochemical evaluation including hormone receptor status

Presented in part as oral presentation at XXV Congress of International Academy of Pathology, Brisbane, Australia. October 10 to 15, 2004.

  • Mohammed T. Idrees

      Affiliations

    • Department of Pathology, The Lilian and Henry M. Stratton-Hans Popper, Mount Sinai Medical Center, New York, NY 10029, USA
  • ,
  • Benjamin L. Hoch

      Affiliations

    • Department of Pathology, The Lilian and Henry M. Stratton-Hans Popper, Mount Sinai Medical Center, New York, NY 10029, USA
  • ,
  • Beverly Y. Wang

      Affiliations

    • Department of Pathology, The Medical College of Georgia, Augusta, GA 30912, USA
  • ,
  • Pamela D. Unger, MD

      Affiliations

    • Department of Pathology, The Lilian and Henry M. Stratton-Hans Popper, Mount Sinai Medical Center, New York, NY 10029, USA
    • Corresponding Author InformationCorresponding author. Department of Pathology, Mount Sinai School of Medicine, Box #1194, New York, NY 10029, USA. Tel.: +1 212 241 9116; fax: +1 212 289 2899.

Abstract 

Aggressive angiomyxoma (AA), first described by Steeper and Rosai (Am J Surg Pathol. 1983;7:463-475), is a rare locally infiltrative tumor that usually arises in the pelvic and perineal soft tissues of young women. Approximately 150 cases have been reported in women. Aggressive angiomyxoma has a high rate of local recurrence because of its infiltrative growth and anatomical location making complete excision with wide margins difficult. To our knowledge, 39 cases of AA occurring in men have been reported in the literature. Sites frequently involved include the scrotum, spermatic cord, inguinal region, and perineum. The gross and microscopic appearances and clinical course are similar to those described in female cases. Immunohistochemistry evaluating estrogen and progesterone receptors (ER and PR, respectively), although frequently positive in the female cases, has rarely been studied in the male cases. We report the clinicopathologic features of 4 additional cases of AA in men with particular emphasis on hormone (ER/PR) receptor status. Hormone reactivity is significant in that AA may arise from specialized hormonally responsive stromal cells of the perineum and may potentially play a therapeutic role in unresectable tumors. From our small series, hormone positivity (1 case of ER+, 3 cases of PR+) does occur in the male cases of AA, and a large number of cases should be examined to determine the frequency at which these tumors express hormone receptors.

Keywords: Angiomyxoma, Hormone, Genitals

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1092-9134(05)00155-3

doi:10.1016/j.anndiagpath.2005.09.002

Annals of Diagnostic Pathology
Volume 10, Issue 4 , Pages 197-204, August 2006